Drug Type Small molecule drug |
Synonyms ERX-245 |
Target |
Mechanism ERs antagonists(Estrogen receptors antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Preclinical | US | 23 Jun 2020 | |
Breast Cancer | Preclinical | US | 23 Jun 2020 |